IL100386A - Suitable free vaccine against virus - Google Patents

Suitable free vaccine against virus

Info

Publication number
IL100386A
IL100386A IL10038691A IL10038691A IL100386A IL 100386 A IL100386 A IL 100386A IL 10038691 A IL10038691 A IL 10038691A IL 10038691 A IL10038691 A IL 10038691A IL 100386 A IL100386 A IL 100386A
Authority
IL
Israel
Prior art keywords
cell
free
vaccine
virus
viruses
Prior art date
Application number
IL10038691A
Other languages
English (en)
Hebrew (he)
Other versions
IL100386A0 (en
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8205666&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL100386(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of IL100386A0 publication Critical patent/IL100386A0/xx
Publication of IL100386A publication Critical patent/IL100386A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16361—Methods of inactivation or attenuation
    • C12N2710/16364—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL10038691A 1990-12-24 1991-12-16 Suitable free vaccine against virus IL100386A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP90314297 1990-12-24

Publications (2)

Publication Number Publication Date
IL100386A0 IL100386A0 (en) 1992-09-06
IL100386A true IL100386A (en) 1995-07-31

Family

ID=8205666

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10038691A IL100386A (en) 1990-12-24 1991-12-16 Suitable free vaccine against virus

Country Status (17)

Country Link
US (1) US5378467A (de)
EP (1) EP0496135B1 (de)
JP (1) JP3410744B2 (de)
KR (1) KR100187317B1 (de)
CN (1) CN1034554C (de)
AT (1) ATE109007T1 (de)
CA (1) CA2058386C (de)
DE (1) DE69103130T2 (de)
DK (1) DK0496135T3 (de)
DZ (1) DZ1550A1 (de)
ES (1) ES2061165T3 (de)
HU (2) HUT62200A (de)
IL (1) IL100386A (de)
MX (1) MX9102757A (de)
NZ (1) NZ241122A (de)
SA (1) SA92120430B1 (de)
ZA (1) ZA9110022B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (de) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Virusimpfstoff gegen Mareksche Krankheit
US5565202A (en) * 1994-08-12 1996-10-15 The United States Of America As Represented By The Secretary Of Agriculture Low enhancement serotype 2 vaccine for marek's disease
FR2857671B1 (fr) * 2003-07-18 2007-10-05 Centre Nat Rech Scient Nouveau procede de culture de keratinocytes et ses applications
DK2384761T3 (da) * 2010-05-07 2013-12-09 Deutsches Krebsforsch Modificeret gnaverparvovirus, som er i stand til formering og spredning i humane gliomer
CN111542337A (zh) 2017-12-20 2020-08-14 英特维特国际股份有限公司 用于细胞相关联的α疱疹病毒疫苗的改良稀释剂

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine
US4895718A (en) * 1987-07-10 1990-01-23 The United States Of America, As Represented By The Secretary Of Agriculture Serotype 2 Marek's disease vaccine
JPS62212326A (ja) * 1987-09-14 1987-09-18 Gen Corp:Kk マレツク病２価生ワクチンとその製造方法

Also Published As

Publication number Publication date
DE69103130D1 (de) 1994-09-01
CA2058386A1 (en) 1992-06-25
JPH04295433A (ja) 1992-10-20
KR100187317B1 (ko) 1999-05-01
US5378467A (en) 1995-01-03
EP0496135B1 (de) 1994-07-27
HUT62200A (en) 1993-04-28
ES2061165T3 (es) 1994-12-01
NZ241122A (en) 1992-10-28
EP0496135A3 (de) 1992-08-05
CN1034554C (zh) 1997-04-16
DK0496135T3 (da) 1994-11-28
JP3410744B2 (ja) 2003-05-26
MX9102757A (es) 1992-07-01
ATE109007T1 (de) 1994-08-15
IL100386A0 (en) 1992-09-06
SA92120430B1 (ar) 2004-05-31
CA2058386C (en) 2003-02-11
EP0496135A2 (de) 1992-07-29
DE69103130T2 (de) 1994-12-01
CN1064409A (zh) 1992-09-16
HU210344A9 (en) 1995-04-28
KR920011520A (ko) 1992-07-24
DZ1550A1 (fr) 2002-02-17
HU914111D0 (en) 1992-03-30
ZA9110022B (en) 1992-10-28

Similar Documents

Publication Publication Date Title
US4530831A (en) Infectious Bursal Disease vaccine
Eidson et al. Immunization against Marek's disease
US3674861A (en) Live attenuated marek{40 s disease virus vaccine for poultry
US5378467A (en) Cell-free Marek's disease virus vaccine
GB1590448A (en) Vaccine and its preparations
DK164846B (da) Mikrobiologisk ren kultur af en infektioes bronkitisvirusstamme
US5686287A (en) Marek's disease virus vaccine
EP1064947B1 (de) In ovo impfung gegen das typ 1 marek's krankheitsvirus
KR0127116B1 (ko) 전염성 점액낭 질병의 예방을 위한 왁찐
EP0760394B1 (de) Milder Newcastle-Krankheitsimpfstoff
US6451321B1 (en) IBDV strain in ovo administration
KR920005661B1 (ko) 생 조합 백신
AU745477B2 (en) Infectious bursitis vaccine
EP0703294A1 (de) Virusimpfstoff gegen Mareksche Krankheit
EP1161953A2 (de) IBDV Stamm für in ovo Verabreichung

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees